Atrial natriuretic peptide (ANP) inhibits DMBA/croton oil induced skin tumor growth by modulating NF-κB, MMPs, and infiltrating mast cells in swiss albino mice-Reference-Cited by-同舟云学术

Atrial natriuretic peptide (ANP) inhibits DMBA/croton oil induced skin tumor growth by modulating NF-κB, MMPs, and infiltrating mast cells in swiss albino mice

Published:2014-10 Issue: Volume:740 Page:388-397
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Subramanian Vimala,Vellaichamy Elangovan

Funder

Department of Biotechnology (DBT)-Grant No. BT/PR6259/FNS/20/587/2012

Indian Council of Medical Research (ICMR)

Publisher

Elsevier BV

Subject

Pharmacology

Reference56 articles.

1. Immunity, inflammation and cancer: a leading role for adenosine;Antonioli;Nat. Rev. Cancer,2013

2. Inflammation and cancer: back to Virchow?;Balkwill;Lancet,2001

3. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels;Beauchamp;Anal. Biochem.,1971

4. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclises;Chang;Nature,1989

5. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis;Chiodoni;Cancer Metastasis Rev.,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C‐type natriuretic peptide (CNP) inhibits 7,12‐Dimethylbenz[a]anthracene (DMBA)/Croton oil‐induced skin tumor growth by modulating inflammation in Swiss albino mice;Journal of Biochemical and Molecular Toxicology;2023-06-23

2. Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes;Seminars in Cancer Biology;2022-12

3. Pleiotropic Roles of Atrial Natriuretic Peptide in Anti-Inflammation and Anti-Cancer Activity;Cancers;2022-08-17

4. Atrial Natriuretic Peptide (ANP) Suppress λ-Carrageenan-Induced Acute Paw Edema by Modulating Pro-inflammatory Genes in Swiss Albino Mice;International Journal of Peptide Research and Therapeutics;2022-08-05

5. Matrixmetalloproteinase Inhibitors: Promising Therapeutic Targets Against Cancer;Current Pharmaceutical Design;2021-11-19